EFFECT OF FLT3 LIGAND ON THE EX-VIVO EXPANSION OF HUMAN CD34(+) HEMATOPOIETIC PROGENITOR CELLS

被引:111
作者
MCKENNA, HJ
DEVRIES, P
BRASEL, K
LYMAN, SD
WILLIAMS, DE
机构
关键词
D O I
10.1182/blood.V86.9.3413.bloodjournal8693413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A ligand for the tyrosine kinase receptor flt3/flk-2, referred to here as flt3 ligand (flt3L), was recently cloned. The effect of flt3L on pu rifled human CD34(+) progenitor cells was examined. flt3 receptor (flt3R) was detected on the surface of human bone marrow cells that were enriched for CD34 expression. The effects of flt3L and the c-kit ligand Steel factor (SLF) on hematopoietic progenitors were compared in clonal colony assays. Both factors synergized with Pixy321 (interleukin-3 [IL-3]-granulocyte-macrophage colony-stimulating factor fusion protein) to induce granulocytic-monocytic (GM) and high proliferative potential (HPP) colonies and synergized with Pixy321 + erythropoietin (EPO) to induce multipotent granulocytic-erythroid-monocytic-megakaryocytic colonies, Although SLF had a potent effect on colony formation of erythroid restricted progenitor cells (burst-forming unit-erythroid), no effect by flt3L was observed. The addition of flt3L to irradiated long-term marrow cultures seeded with CD34(+) cells augmented both total and progenitor cell production. Ex vivo expansion studies with isolated CD34(+) bone marrow cells from normal donors showed that flt3L alone supported maintenance of both GM and HPP progenitors for 3 to 4 weeks in vitro. The addition of flt3L to a growth factor combination of IL-1 alpha + IL-3 + IL-6 + EPO resulted in a synergistic effect on progenitor cell expansion comparable to that observed with the addition of SLF to IL-1 alpha + IL-3 + IL-6 + EPO. These data show a function for flt3L in the regulation of both primitive multipotent and lineage-committed hematopoietic progenitor cells. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:3413 / 3420
页数:8
相关论文
共 38 条
[1]   REGULATION OF INTERLEUKIN-4 RECEPTORS ON HUMAN T-CELLS [J].
ARMITAGE, RJ ;
BECKMANN, MP ;
IDZERDA, RL ;
ALPERT, A ;
FANSLOW, WC .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (11) :1039-1045
[2]  
ASHMAN LK, 1991, BLOOD, V78, P30
[3]  
BERNSTEIN ID, 1991, BLOOD, V77, P2316
[4]  
BRANDT J, 1992, BLOOD, V79, P634
[5]  
BROXMEYER HE, 1991, BLOOD, V77, P2142
[6]  
BRUGGER W, 1993, BLOOD, V81, P2579
[7]   ENHANCED HEMATOPOIETIC ACTIVITY OF A HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSION PROTEIN [J].
CURTIS, BM ;
WILLIAMS, DE ;
BROXMEYER, HE ;
DUNN, J ;
FARRAH, T ;
JEFFERY, E ;
CLEVENGER, W ;
DEROOS, P ;
MARTIN, U ;
FRIEND, D ;
CRAIG, V ;
GAYLE, R ;
PRICE, V ;
COSMAN, D ;
MARCH, CJ ;
PARK, LS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5809-5813
[8]  
DAI CH, 1991, BLOOD, V78, P2493
[9]   CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO [J].
DEXTER, TM ;
ALLEN, TD ;
LAJTHA, LG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) :335-344
[10]  
GABUTTTI V, 1993, STEM CELLS S2, V1, P105